SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-18-006730
Filing Date
2018-05-14
Accepted
2018-05-14 09:17:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 121551
2 ex-1.htm EX-1 8961
  Complete submission text file 0001493152-18-006730.txt   132443
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-48710 | Film No.: 18828912
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G